List of works - Iwona Flisiak

Abnormal serum fatty acid profile in psoriatic arthritis

scientific article published on 01 October 2019

Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin

scientific article published on 08 July 2019

Albinterferon-alfa 2b: a new treatment option for hepatitis C ⬇️

scientific article published on October 1, 2010

Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions

scientific article published on 01 August 2002

Clinical and epidemiological assessment of patients hospitalized for primary and recurrent erysipelas

scientific article published on January 2016

Cutaneous Rosai - Dorfman disease in a patient with late syphilis and cervical cancer - case report and a review of literature

scientific article published on 07 December 2020

Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).

scientific article

Dysfunkcje seksualne w wybranych przewlekłych dermatozach

scientific article published in 2022

Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B

scientific article

Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.

scientific article

Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).

scientific article published on 6 July 2017

Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels

scientific article published on 11 May 2016

Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.

scientific article published on 25 December 2012

Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.

scientific article

Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.

scientific article

Effect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scales

scientific article published on 01 January 2006

Effect of psoriasis activity on serum adiponectin and leptin levels.

scientific article published on 30 March 2015

Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations

scientific article published on 21 March 2011

Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.

scientific article published in July 2005

Enhanced Inflammation and Nitrosative Stress in the Saliva and Plasma of Patients with Plaque Psoriasis

scientific article published on 10 March 2020

Evaluation of CD40, its ligand CD40L and Bcl-2 in psoriatic patients

scientific article published on April 24, 2012

Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis ⬇️

scientific article published on 28 June 2020

Incidence of pemphigus vulgaris and pemphigus foliaceus in North-East Poland (Podlaskie Province) - a 15-year (2001-2015) bicentric retrospective study

scientific article published on 05 June 2018

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients

scientific article published on 17 December 2016

Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients with psoriasis

scientific article published on 27 July 2017

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis.

scientific article published on 16 April 2019

Lp-PLA2 as a promising predictor of comorbidities in patients with severe psoriasis

scientific article published on 18 April 2019

Men treated for syphilis in Białystok, Poland,2014-2018

scientific article published on 01 January 2019

Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data

scientific article published on 26 March 2020

Plasma TGF-beta1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity

scientific article published on 01 August 2008

Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activity

scientific article published on 01 March 2006

Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B

scientific article published on 01 November 2005

Plasma transforming growth factor β1as a biomarker of psoriasis activity and treatment efficacy ⬇️

scientific article published on September 1, 2003

Plasma transforming growth factor-beta(1) in acute viral hepatitis.

scientific article published on 25 May 2005

Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein-Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome? ⬇️

scientific article published on 23 May 2020

Rare coexistence of unilateral erythema nodosum with erysipelas in the area of previous adder bite

scientific article published on 01 January 2020

Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?

scientific article published on 03 January 2020

Scabies –still current medical and social problem. A retrospective analysis of 193 cases

scientific article published on 01 January 2019

Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis

scientific article

Serum YKL-40 as a potential biomarker of inflammation in psoriasis

scientific article published on 12 May 2017

Serum adiponectin and leptin levels in psoriatic patients according to topical treatment.

scientific article

Serum fatty acid profile in psoriasis and its comorbidity

scientific article

Serum irisin levels in patients with psoriasis.

scientific article

Serum sphingolipid level in psoriatic patients with obesity

scientific article published on 30 December 2019

Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C.

scientific article

The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients

scientific article published on 13 December 2019

The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.

scientific article published on 21 August 2015

Update on alisporivir in treatment of viral hepatitis C.

scientific article published on 8 February 2012

Upregulation of the sFas/sFasL system in psoriatic patients

scientific article published on 4 November 2014

What do you know about sexually transmitted infections? Survey concerning knowledge and risky behaviors among students of Białystok universities

scientific article published on 01 January 2020

[The role of metalloproteinases in psoriasis].

scientific article

[The role of tumor necrosis factor alpha receptors (TNF-alpha) in psoriasis and other skin disorders]

scientific article published on 01 January 2004

List of works by Iwona Flisiak

Abnormal serum fatty acid profile in psoriatic arthritis

Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin

Albinterferon-alfa 2b: a new treatment option for hepatitis C ⬇️

Association between psoriasis severity and transforming growth factor beta(1) and beta (2) in plasma and scales from psoriatic lesions

Clinical and epidemiological assessment of patients hospitalized for primary and recurrent erysipelas

Cutaneous Rosai - Dorfman disease in a patient with late syphilis and cervical cancer - case report and a review of literature

Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).

Dysfunkcje seksualne w wybranych przewlekłych dermatozach

Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B

Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.

Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).

Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels

Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.

Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.

Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.

Effect of psoriasis activity on metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in plasma and lesional scales

Effect of psoriasis activity on serum adiponectin and leptin levels.

Effect of psoriasis therapy on VEGF and its soluble receptors serum concentrations

Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.

Enhanced Inflammation and Nitrosative Stress in the Saliva and Plasma of Patients with Plaque Psoriasis

Evaluation of CD40, its ligand CD40L and Bcl-2 in psoriatic patients

Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis ⬇️

Incidence of pemphigus vulgaris and pemphigus foliaceus in North-East Poland (Podlaskie Province) - a 15-year (2001-2015) bicentric retrospective study

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients

Influence of narrowband ultraviolet B phototherapy on serum tumour necrosis factor-like weak inducer of apoptosis (TWEAK) in patients with psoriasis

Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis.

Lp-PLA2 as a promising predictor of comorbidities in patients with severe psoriasis

Men treated for syphilis in Białystok, Poland,2014-2018

Methotrexate Decreases the Level of PCSK9-A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data

Plasma TGF-beta1, TIMP-1, MMP-1 and IL-18 as a combined biomarker of psoriasis activity

Plasma and scales levels of interleukin 18 in comparison with other possible clinical and laboratory biomarkers of psoriasis activity

Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B

Plasma transforming growth factor β1as a biomarker of psoriasis activity and treatment efficacy ⬇️

Plasma transforming growth factor-beta(1) in acute viral hepatitis.

Proprotein Convertase Subtilisin/Kexin Type 9, Angiopoietin-Like Protein 8, Sortilin, and Cholesteryl Ester Transfer Protein-Friends of Foes for Psoriatic Patients at the Risk of Developing Cardiometabolic Syndrome? ⬇️

Rare coexistence of unilateral erythema nodosum with erysipelas in the area of previous adder bite

Salivary Antioxidants and Oxidative Stress in Psoriatic Patients: Can Salivary Total Oxidant Status and Oxidative Status Index Be a Plaque Psoriasis Biomarker?

Scabies –still current medical and social problem. A retrospective analysis of 193 cases

Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis

Serum YKL-40 as a potential biomarker of inflammation in psoriasis

Serum adiponectin and leptin levels in psoriatic patients according to topical treatment.

Serum fatty acid profile in psoriasis and its comorbidity

Serum irisin levels in patients with psoriasis.

Serum sphingolipid level in psoriatic patients with obesity

Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C.

The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients

The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.

Update on alisporivir in treatment of viral hepatitis C.

Upregulation of the sFas/sFasL system in psoriatic patients

What do you know about sexually transmitted infections? Survey concerning knowledge and risky behaviors among students of Białystok universities

[The role of metalloproteinases in psoriasis].

[The role of tumor necrosis factor alpha receptors (TNF-alpha) in psoriasis and other skin disorders]

[Vitamin D deficiency in psoriatic patients in north-east of Poland]